Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Reversing Therapy Resistance With Epigenetic-Immune Modification

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02395627
Recruitment Status : Active, not recruiting
First Posted : March 23, 2015
Last Update Posted : January 22, 2019
Information provided by (Responsible Party):
Pamela Munster, University of California, San Francisco

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 20, 2019
Estimated Study Completion Date : December 20, 2021